Nadav Kidron

What we try to do at Oramed is to take insulin, which currently can only be given as an injection, and we have the technology to take insulin and deliver it orally.

Okay, so you, thank God you don't have diabetes, but when you look around you, you know, almost 10% of the population suffers from diabetes.

The lifestyle that we have results in many, many, many people who suffer from diabetes.

The problem when someone has diabetes is,

When he starts with a type 2, he cannot produce enough insulin or there is an insulin resistance and they don't want to go on the injection.

And what we offer them is a new paradigm, a new way to treat diabetes by giving them insulin as an earlier treatment and pushing away the point that they become insulin dependent where the major complications can happen at that point in time.

Yeah, there's a huge difference because when you take an injection, it goes straight into your bloodstream.

But when we give it orally, it actually goes into the liver.

And the liver is the organ that regulates the secretion of the insulin into the bloodstream.

We're able to mimic the physiological way that the body works.

Because if you take something like an insulin and you put it in your mouth, it gets degraded.

And the size of the insulin does not allow it to go into the bloodstream.

So we have a technology that was actually developed by my mother, who is a scientist that allows us to protect the insulin from degradation and to take it intact into the liver.

Yeah, so there is a hard shell part of it as well.

But the real thing is that there's enzymes that they basically cause the degradation.

And we have sort of an anti-enzyme that knows how to protect from those enzymes.

So think about it like a shield that protects.

And this is exactly what we have.

So we're sort of in between because we have some revenues because we had a large licensing deal with China that basically gave us

$50 million, but we still don't have the product in the market because we have to finalize the process with the FDA.